339 related articles for article (PubMed ID: 26045309)
1. Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET.
Chen YJ; Rosario BL; Mowrey W; Laymon CM; Lu X; Lopez OL; Klunk WE; Lopresti BJ; Mathis CA; Price JC
J Nucl Med; 2015 Aug; 56(8):1199-205. PubMed ID: 26045309
[TBL] [Abstract][Full Text] [Related]
2. Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of β-Amyloid Images.
Sojkova J; Goh J; Bilgel M; Landman B; Yang X; Zhou Y; An Y; Beason-Held LL; Kraut MA; Wong DF; Resnick SM
J Nucl Med; 2015 Jul; 56(7):1042-7. PubMed ID: 25977462
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous assessment of blood flow and myelin content in the brain white matter with dynamic [11 C]PiB PET: a test-retest study in healthy controls.
Yazdan-Panah A; Bodini B; Soulier T; Veronese M; Bottlaender M; Tonietto M; Stankoff B
EJNMMI Res; 2024 May; 14(1):50. PubMed ID: 38801594
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.
Rodriguez-Vieitez E; Carter SF; Chiotis K; Saint-Aubert L; Leuzy A; Schöll M; Almkvist O; Wall A; Långström B; Nordberg A
J Nucl Med; 2016 Jul; 57(7):1071-7. PubMed ID: 26912447
[TBL] [Abstract][Full Text] [Related]
5. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
Lopresti BJ; Klunk WE; Mathis CA; Hoge JA; Ziolko SK; Lu X; Meltzer CC; Schimmel K; Tsopelas ND; DeKosky ST; Price JC
J Nucl Med; 2005 Dec; 46(12):1959-72. PubMed ID: 16330558
[TBL] [Abstract][Full Text] [Related]
6. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
[TBL] [Abstract][Full Text] [Related]
7. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
[TBL] [Abstract][Full Text] [Related]
8. Early Phase PIB-PET as a Surrogate for Global and Regional Cerebral Blood Flow Measures.
Ponto LLB; Moser DJ; Menda Y; Harlynn EL; DeVries SD; Oleson JJ; Magnotta VA; Schultz SK
J Neuroimaging; 2019 Jan; 29(1):85-96. PubMed ID: 30461110
[TBL] [Abstract][Full Text] [Related]
9. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
Price JC; Klunk WE; Lopresti BJ; Lu X; Hoge JA; Ziolko SK; Holt DP; Meltzer CC; DeKosky ST; Mathis CA
J Cereb Blood Flow Metab; 2005 Nov; 25(11):1528-47. PubMed ID: 15944649
[TBL] [Abstract][Full Text] [Related]
10. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A
J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal amyloid imaging using 11C-PiB: methodologic considerations.
van Berckel BN; Ossenkoppele R; Tolboom N; Yaqub M; Foster-Dingley JC; Windhorst AD; Scheltens P; Lammertsma AA; Boellaard R
J Nucl Med; 2013 Sep; 54(9):1570-6. PubMed ID: 23940304
[TBL] [Abstract][Full Text] [Related]
12. [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.
Hatashita S; Yamasaki H; Suzuki Y; Tanaka K; Wakebe D; Hayakawa H
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):290-300. PubMed ID: 24085503
[TBL] [Abstract][Full Text] [Related]
13. Simulating the effect of cerebral blood flow changes on regional quantification of [
Heeman F; Yaqub M; Lopes Alves I; Heurling K; Bullich S; Gispert JD; Boellaard R; Lammertsma AA;
J Cereb Blood Flow Metab; 2021 Mar; 41(3):579-589. PubMed ID: 32281514
[TBL] [Abstract][Full Text] [Related]
14. Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET.
Rosario BL; Weissfeld LA; Laymon CM; Mathis CA; Klunk WE; Berginc MD; James JA; Hoge JA; Price JC
Neuroimage; 2011 Apr; 55(3):933-41. PubMed ID: 21195782
[TBL] [Abstract][Full Text] [Related]
15. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
Rabinovici GD; Furst AJ; O'Neil JP; Racine CA; Mormino EC; Baker SL; Chetty S; Patel P; Pagliaro TA; Klunk WE; Mathis CA; Rosen HJ; Miller BL; Jagust WJ
Neurology; 2007 Apr; 68(15):1205-12. PubMed ID: 17420404
[TBL] [Abstract][Full Text] [Related]
16. Test-Retest Variability of Relative Tracer Delivery Rate as Measured by [
Heeman F; Hendriks J; Lopes Alves I; Tolboom N; van Berckel BNM; Yaqub M; Lammertsma AA
Mol Imaging Biol; 2021 Jun; 23(3):335-339. PubMed ID: 33884565
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
Aalto S; Scheinin NM; Kemppainen NM; Någren K; Kailajärvi M; Leinonen M; Scheinin M; Rinne JO
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1651-60. PubMed ID: 19495749
[TBL] [Abstract][Full Text] [Related]
18. Relative equilibrium plot improves graphical analysis and allows bias correction of standardized uptake value ratio in quantitative 11C-PiB PET studies.
Zhou Y; Sojkova J; Resnick SM; Wong DF
J Nucl Med; 2012 Apr; 53(4):622-8. PubMed ID: 22414634
[TBL] [Abstract][Full Text] [Related]
19. Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?
Oliveira FPM; Moreira AP; de Mendonça A; Verdelho A; Xavier C; Barroca D; Rio J; Cardoso E; Cruz Â; Abrunhosa A; Castelo-Branco M
J Alzheimers Dis; 2018; 65(1):89-97. PubMed ID: 30056421
[TBL] [Abstract][Full Text] [Related]
20. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.
Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A
J Alzheimers Dis; 2015; 45(4):1077-88. PubMed ID: 25649653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
